Seehra Jasbir 4
4 · Keros Therapeutics, Inc. · Filed Apr 11, 2023
Insider Transaction Report
Form 4
Seehra Jasbir
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Exercise/Conversion
Common Stock
2023-04-08$0.48/sh+4,000$1,920→ 252,856 total - Exercise/Conversion
Employee Stock Option (right to buy)
2023-04-08−4,000→ 45,087 totalExercise: $0.48Exp: 2029-06-18→ Common Stock (4,000 underlying)
Footnotes (1)
- [F1]Fully vested and exercisable.